Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging

Brito,João A.R.; Gomes,Carolina C.; Pimenta,Flávio J.G.S.; Barbosa,Alvimar A.; Prado,Marco A.M.; Prado,Vânia F.; Gomez,Marcus V.; Gomez,Ricardo S.

doi:10.3892/etm_00000035

Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging

Authors:
- João A.R. Brito
- Carolina C. Gomes
- Flávio J.G.S. Pimenta
- Alvimar A. Barbosa
- Marco A.M. Prado
- Vânia F. Prado
- Marcus V. Gomez
- Ricardo S. Gomez
View Affiliations

Affiliations: Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Published online on: January 1, 2010 https://doi.org/10.3892/etm_00000035
Pages: 217-221

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) mir15a and let7a are important regulators of bcl-2, ras and c-myc proteins. Considering that these miRNAs are commonly altered in many human cancers and that these proteins are reported to be altered in oral squamous cell carcinoma (OSCC), we investigated them in a set of OSCC cases. The miRNAs as well as the proteins were evaluated in the tumor and blood of 20 patients by real-time quantitative PCR and immunohistochemistry, respectively. The expression of mir15a and bcl-2 proteins in the tumors was not associated with each other or with tumor staging. On the other hand, we found reduced expression of this miRNA in the blood of patients with an advanced stage of OSCC and with lymph node metastasis. The expression of let7a in the tumor and blood was not associated with tumor size, lymph node metastasis, tumor staging and immunoexpression of ras and c-myc proteins. In conclusion, the present study shows that reduced expression of mir15a is associated with OSCC staging.

View Figures

View References

1.	Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
2.	Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Huppi K, Volfovsky N, Mackiewicz M, et al: MicroRNAs and genomic instability. Semin Cancer Biol. 17:65–73. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Kent OA and Mendell JT: A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 39:673–677. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Warnasulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009. View Article : Google Scholar
7.	Gomes CC and Gomez RS: MicroRNA and oral cancer. Oral Oncol. 44:910–914. 2008. View Article : Google Scholar : PubMed/NCBI
8.	Barnes L, Everson JW, Reichart P and Sidransky D: WHO - World Health Organization Classification of Tumours, Pathology and Genetics of Head and Neck Tumours. IARC Press; Lyon: pp. 4332005
9.	Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
10.	Livak KJ and Schimittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 25:402–408. 2001.
11.	Tran N, McLean T, Zhang X, et al: MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun. 358:12–17. 2007. View Article : Google Scholar
12.	Jiang J, Lee EJ, Gusev Y and Schimittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 33:5394–5403. 2005. View Article : Google Scholar : PubMed/NCBI
13.	Gaur A, Jewell DA, Liang Y, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
15.	Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
16.	Camisasca DR, Honorato J, Bernardo V, et al: Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol. 45:225–233. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Ohigashi T, Ueno N, Novaka S, et al: Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells. Am J Physiol Cell Physiol. 278:C66–C72. 2000.PubMed/NCBI
18.	Ogawara K, Miyakawa A, Shiba M, et al: Allelic loss of chromosome 13q14.3 in human oral cancer correlation with lymph node metastasis. Int J Cancer. 79:312–317. 1998. View Article : Google Scholar : PubMed/NCBI
19.	Takamizawa J, Konishi H, Yanagizawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Akao Y, Nakagawa Y and Naoe T: Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Childs G, Fazzari M, Kung G, et al: Low-level expression of microRNAs let-7d and mir-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol. 174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
22.	Chang KW, Liu CJ, Chu TH, et al: Association between high mir-211 microRNA Expression and the poor prognosis of oral carcinoma. J Dent Res. 87:1063–1068. 2008. View Article : Google Scholar : PubMed/NCBI
23.	Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell. 120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
24.	Christensen BC, Moyer BJ, Avissar M, et al: Let-7 microRNA binging site polymorphism in the KRAS 3′UTR is associated with reduced survival in oral cancers. Carcinogenesis. 30:1003–1007. 2009.
25.	Perez-Ordoñez B, Beauchemin M and Jordan RCK: Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol. 59:445–453. 2006.
26.	Hardisson D: Molecular pathogenesis of head and neck squamous cell carcinoma. Head Neck Oncol. 260:502–508. 2003.PubMed/NCBI
27.	Das BR and Nagpal JK: Understanding the biology of oral cancer. Med Sci Monit. 8:258–267. 2002.
28.	Fukasawa K: Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 230:6–19. 2005. View Article : Google Scholar